Neuro-Oncology Reviews

Volume 25 Number 12
30 June 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 12, 30 June

Chan P, Rich JN, Kay SA.
Watching the Clock in Glioblastoma.
Neuro Oncol. 2023 Jun 16:noad107. doi: 10.1093/neuonc/noad107. PMID: 37326042. Review. ˍ

Grønbæk JK, Boeg Thomsen D, Persson K, Mathiasen R, Juhler M.
The Cerebellar Mutism Syndrome: Risk Assessment, Prevention and Treatment.
Adv Tech Stand Neurosurg. 2023 Jun 16;46:65-94. doi: 10.1007/978-3-031-28202-7_4. PMID: 37318570. Review, Book chapter˰ ˍ

Mijderwijk HJ.
Evolution of Making Clinical Predictions in Neurosurgery.
Adv Tech Stand Neurosurg. 2023 Jun 16;46:109-123. doi: 10.1007/978-3-031-28202-7_6. PMID: 37318572. Review, Book chapter˰ ˍ

Miller DC.
The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Adv Tech Stand Neurosurg. 2023 Jun 16;46:1-21. doi: 10.1007/978-3-031-28202-7_1. PMID: 37318567. Review, Book chapter˰ ˍ

Salomão JFM, Protzenko T.
Intracranial Tumors in the First Year of Life.
Adv Tech Stand Neurosurg. 2023 Jun 16;46:23-52. doi: 10.1007/978-3-031-28202-7_2. PMID: 37318568. Review, Book chapter˰ ˍ

Spina S, Facciorusso S, Cinone N, Pellegrino R, Fiore P, Santamato A.
Rehabilitation interventions for glioma patients: a mini-review.
Front Surg. 2023 Jun 16;10:1137516. doi: 10.3389/fsurg.2023.1137516. PMID: 37396290. Review. ˍ

Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, Moradi-Vastegani S, Bahramvand Y, Babaniamansour S, Jafarzadeh E.
Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.
Acta Histochem. 2023 Jun 17;125(6):152058. doi: 10.1016/j.acthis.2023.152058. PMID: 37336070. Review˰ ˍ

Nowak M, Górczyńska J, Kołodzińska K, Rubin J, Choromańska A.
Extracellular Vesicles as Drug Transporters.
Int J Mol Sci. 2023 Jun 17;24(12):10267. doi: 10.3390/ijms241210267. PMID: 37373411. Review. ˍ

Zhang SP, He C, Wang XP, Wang B, Tang ZW.
Case report of epileptic seizure during awake craniotomy of functional area glioma and literature study.
Int Rev Neurobiol. 2023 Jun 17;172:321-331. doi: 10.1016/bs.irn.2023.05.016. PMID: 37833017.
Case report, Review. ˍ

Ji X, Ding W, Wang J, Zhou B, Li Y, Jiang W, Pan H, Gu J, Sun X.
Application of intraoperative radiotherapy for malignant glioma.
Cancer Radiother. 2023 Jun 19:S1278-3218(23)00066-5. doi: 10.1016/j.canrad.2023.01.007. PMID: 37344258. Review˰ ˍ

Kehoe K, Sivaguru H, Coulter I, Cowie C.
Delay in the diagnosis of paediatric brain tumours: a systematic review.
Childs Nerv Syst. 2023 Jun 19. doi: 10.1007/s00381-023-06022-y. PMID: 37336792. Review˰ ˍ

Mendez Valdez MJ, Kim E, Bhatia S, Saad AG, Sidani C, Daggubati L, Chandar J, Seetharam D, Desgraves J, Ingle S, Luther E, Ivan M, Komotar R, Shah AH.
Outcomes of HSV-1 encephalitis infection in glioblastoma: An integrated systematic analysis.
Microb Pathog. 2023 Jun 19:106211. doi: 10.1016/j.micpath.2023.106211. PMID: 37343897. Meta-analysis˰ ˍ

Xiong Q, Zhu J, Zhang Y, Deng H.
CAR-NK cell therapy for glioblastoma: what to do next?
Front Oncol. 2023 Jun 19;13:1192128. doi: 10.3389/fonc.2023.1192128. PMID: 37404752. Review. ˍ

Zhong J, Lu J, Zhang G, Mao S, Chen H, Yin Q, Hu Y, Xing Y, Ding D, Ge X, Zhang H, Yao W.
An overview of meta-analyses on radiomics: more evidence is needed to support clinical translation.
Insights Imaging. 2023 Jun 19;14(1):111. doi: 10.1186/s13244-023-01437-2. PMID: 37336830. Review. ˍ

Wang J, Liu Y, Liu F, Gan S, Roy S, Hasan I, Zhang B, Guo B.
Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy.
Nanoscale. 2023 Jun 20. doi: 10.1039/d3nr01667f. PMID: 37337814. Review˰ ˍ

Yoshikawa MH, Rabelo NN, Telles JPM, Figueiredo EG.
Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.
Neurosurg Rev. 2023 Jun 20;46(1):143. doi: 10.1007/s10143-023-02051-y. PMID: 37340151. Review, Meta-analysis˰ ˍ

Huo H, Shen S, Yang Y, Zhang H, Wu S, Bi T, Li Y.
The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.
J Thromb Thrombolysis. 2023 Jun 21. doi: 10.1007/s11239-023-02851-5. PMID: 37341895. Meta-analysis˰ ˍ

Muzyka L, Goff NK, Choudhary N, Koltz MT.
Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
Int J Mol Sci. 2023 Jun 21;24(13):10456. doi: 10.3390/ijms241310456. PMID: 37445633. Review. ˍ

Wala JA, Hanna GJ.
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors.
Hematol Oncol Clin North Am. 2023 Jun 21:S0889-8588(23)00064-3. doi: 10.1016/j.hoc.2023.05.009. PMID: 37353377. Review˰ ˍ

Soldozy S, Eichberg DG, Morell AA, Luther E, Lu VM, Higgins DMO, Patel NV, Shah AH, Hanft SJ, Komotar RJ, Ivan ME.
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice.
Pathogens. 2023 Jun 22;12(7):861. doi: 10.3390/pathogens12070861. PMID: 37513708. Review. ˍ

Vuu YM, Kadar Shahib A, Rastegar M.
The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action.
Pharmaceuticals (Basel). 2023 Jun 22;16(7):914. doi: 10.3390/ph16070914. PMID: 37513826. Review. ˍ

Das S, Dash BS, Premji TP, Chen JP.
Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications.
Int J Mol Sci. 2023 Jun 23;24(13):10546. doi: 10.3390/ijms241310546. PMID: 37445721. Review. ˍ

Hassanipour S, Nikbakht HA, Amrane A, Arab-Zozani M, Shojaie L, Rostami S, Badeenezhad A.
The Relationship between Air Pollution and Brain Cancer: A Systematic Review and Meta-Analysis.
Ann Glob Health. 2023 Jun 23;89(1):45. doi: 10.5334/aogh.3889. PMID: 37362828. Review, Meta-analysis. ˍ

Vanbilloen WJF, Rechberger JS, Anderson JB, Nonnenbroich LF, Zhang L, Daniels DJ.
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors.
Pharmaceutics. 2023 Jun 23;15(7):1804. doi: 10.3390/pharmaceutics15071804. PMID: 37513992. Review. ˍ

Boylan J, Byers E, Kelly DF.
The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities.
Med Res Arch. 2023 Jun 26;11(6):10.18103/mra.v11i6.3994. doi: 10.18103/mra.v11i6.3994. PMID: 38107346. Review.

Kim YM, Kitlinska JB.
Editorial: Women in pediatric oncology Vol II: 2022.
Front Oncol. 2023 Jun 26;13:1223296. doi: 10.3389/fonc.2023.1223296. PMID: 37434976. Editorial. ˍ

Jumapili NA, Zivalj M, Barthelmess RM, Raes G, De Groof TWM, Devoogdt N, Stijlemans B, Vincke C, Van Ginderachter JA.
A few good reasons to use nanobodies for cancer treatment.
Eur J Immunol. 2023 Jun 27:e2250024. doi: 10.1002/eji.202250024. PMID: 37366246. Review. ˍ

Boltman T, Meyer M, Ekpo O.
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles.
Cancers (Basel). 2023 Jun 28;15(13):3388. doi: 10.3390/cancers15133388. PMID: 37444498. Review. ˍ

Larsen PA, Amidi A, Ghith N, Winther JF, Pedersen C.
Quality of life of adolescent and adult survivors of childhood cancer in Europe-A systematic review.
Int J Cancer. 2023 Jun 28. doi: 10.1002/ijc.34634. PMID: 37377041. Review. ˍ

Ragucci F, Sireci F, Cavallieri F, Rossi J, Biagini G, Tosi G, Lucchi C, Molina-Pena R, Ferreira NH, Zarur M, Ferreiros A, Bourgeois W, Berger F, Abal M, Rousseau A, Boury F, Alvarez-Lorenzo C, Garcion E, Pisanello A, Pavesi G, Iaccarino C, Ghirotto L, Bassi MC, Valzania F.
Insights into Healthcare Professionals' Perceptions and Attitudes toward Nanotechnological Device Application: What Is the Current Situation in Glioblastoma Research?
Biomedicines. 2023 Jun 28;11(7):1854. doi: 10.3390/biomedicines11071854. PMID: 37509494. Review. ˍ

Tosi U, Souweidane M.
Fifty years of DIPG: looking at the future with hope.
Childs Nerv Syst. 2023 Jun 29. doi: 10.1007/s00381-023-06037-5. PMID: 37382660. Review˰ ˍ

Bhanja D, Wilding H, Baroz A, Trifoi M, Shenoy G, Slagle-Webb B, Hayes D, Soudagar Y, Connor J, Mansouri A.
Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability.
Cancers (Basel). 2023 Jun 30;15(13):3427. doi: 10.3390/cancers15133427. PMID: 37444537. Review. ˍ

Halawa T, Baeesa S, Fadul MM, Badahdah AA, Enani M, Fathaddin AA, Kawass D, Alkhotani A, Bahakeem B, Kurdi M.
The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma.
Cureus. 2023 Jun 30;15(6):e41221. doi: 10.7759/cureus.41221. PMID: 37525780. Review. ˍ

Li W, Xu X.
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment.
Front Pharmacol. 2023 Jun 30;14:1211719. doi: 10.3389/fphar.2023.1211719. PMID: 37456742. Review. ˍ


Pu Y, Zhou G, Zhao K, Chen Y, Shen S.
Immunotherapy for Recurrent Glioma-From Bench to Bedside.
Cancers (Basel). 2023 Jun 30;15(13):3421. doi: 10.3390/cancers15133421. PMID: 37444531. Review. ˍ

Rubiano EGO, Baldoncini M, Cómbita AL, Payán-Gómez C, Gómez-Amarillo DF, Hakim F, Figueredo LF, Forlizzi V, Rangel CC, Luzzi S, Campero A, Parra-Medina R.
Understanding the molecular profiling of diffuse gliomas classification: A brief overview.
Surg Neurol Int. 2023 Jun 30;14:225. doi: 10.25259/SNI_209_2023. PMID: 37404501. Review. ˍ